BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1228 related articles for article (PubMed ID: 26067893)

  • 1. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
    Stevens WW; Ocampo CJ; Berdnikovs S; Sakashita M; Mahdavinia M; Suh L; Takabayashi T; Norton JE; Hulse KE; Conley DB; Chandra RK; Tan BK; Peters AT; Grammer LC; Kato A; Harris KE; Carter RG; Fujieda S; Kern RC; Schleimer RP
    Am J Respir Crit Care Med; 2015 Sep; 192(6):682-94. PubMed ID: 26067893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study.
    Chen F; Hong H; Sun Y; Hu X; Zhang J; Xu G; Zhao W; Li H; Shi J
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):310-316.e2. PubMed ID: 28870448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.
    Wei Y; Xia W; Ye X; Fan Y; Shi J; Wen W; Yang P; Li H;
    J Allergy Clin Immunol; 2014 Feb; 133(2):420-8. PubMed ID: 24342548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profiles in Japanese patients with chronic rhinosinusitis.
    Sejima T; Holtappels G; Kikuchi H; Imayoshi S; Ichimura K; Bachert C
    Allergol Int; 2012 Mar; 61(1):115-22. PubMed ID: 22377524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory heterogeneity in aspirin-exacerbated respiratory disease.
    Scott WC; Cahill KN; Milne GL; Li P; Sheng Q; Huang LC; Dennis S; Snyder J; Bauer AM; Chandra RK; Chowdhury NI; Turner JH
    J Allergy Clin Immunol; 2021 Apr; 147(4):1318-1328.e5. PubMed ID: 33189729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.
    Takahashi T; Kato A; Berdnikovs S; Stevens WW; Suh LA; Norton JE; Carter RG; Harris KE; Peters AT; Hulse KE; Grammer LC; Welch KC; Shintani-Smith S; Tan BK; Conley DB; Kern RC; Bochner BS; Schleimer RP
    J Allergy Clin Immunol; 2017 Sep; 140(3):720-729. PubMed ID: 28238741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of cancerous inhibitor protein phosphatase 2A in chronic rhinosinusitis with nasal polyps.
    Terna E; Luukkainen A; Seppälä M; Renkonen R; Huhtala H; Tommola S; Paavonen T; Kauppi P; Tynninen O; Jeskanen L; Toppila-Salmi S
    Acta Otolaryngol; 2016 Nov; 136(11):1173-1179. PubMed ID: 27348236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity has no impact on eosinophil inflammation in the upper airways or on severity of the sinonasal disease in patients with nasal polyps.
    Uhliarova B; Kopincova J; Kolomaznik M; Adamkov M; Svec M; Calkovska A
    Clin Otolaryngol; 2015 Oct; 40(5):429-36. PubMed ID: 25688693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese.
    Cao PP; Li HB; Wang BF; Wang SB; You XJ; Cui YH; Wang DY; Desrosiers M; Liu Z
    J Allergy Clin Immunol; 2009 Sep; 124(3):478-84, 484.e1-2. PubMed ID: 19541359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.
    Min JY; Ocampo CJ; Stevens WW; Price CPE; Thompson CF; Homma T; Huang JH; Norton JE; Suh LA; Pothoven KL; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Harris KE; Hulse KE; Kato A; Modyanov NN; Kern RC; Schleimer RP; Tan BK
    J Allergy Clin Immunol; 2017 Jan; 139(1):130-141.e11. PubMed ID: 27717558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid-induced leucine zipper.
    Zhang XH; Lu X; Long XB; You XJ; Gao QX; Cui YH; Liu Z
    Clin Exp Allergy; 2009 May; 39(5):647-54. PubMed ID: 19260870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.
    Sohail A; Hacker J; Ryan T; McGill A; Bergmark R; Bhattacharyya N; Lee SE; Maxfield A; Roditi R; Julé AM; Griffith A; Lederer J; Laidlaw TM; Buchheit KM
    J Allergy Clin Immunol; 2024 Feb; 153(2):527-532. PubMed ID: 37898408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polyps.
    Weibman AR; Huang JH; Stevens WW; Suh LA; Price CPE; Lidder AK; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Kato A; Kern RC; Schleimer RP; Tan BK
    Int Forum Allergy Rhinol; 2017 Nov; 7(11):1058-1064. PubMed ID: 28863237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased IL-21 expression in chronic rhinosinusitis with nasalpolyps.
    Xiao L; Wei Y; Zhang YN; Luo X; Yang BY; Yu SF; Wu XM; Wu CY; Li HB
    Clin Exp Allergy; 2015 Feb; 45(2):404-13. PubMed ID: 25495679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of fibrinolytic components in chronic paranasal sinus disease.
    Sejima T; Holtappels G; Bachert C
    Am J Rhinol Allergy; 2011; 25(1):1-6. PubMed ID: 21711960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced sinonasal levels of 1α-hydroxylase are associated with worse quality of life in chronic rhinosinusitis with nasal polyps.
    Schlosser RJ; Carroll WW; Soler ZM; Pasquini WN; Mulligan JK
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):58-65. PubMed ID: 26575398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Chen D; Mao M; Bellussi LM; Passali D; Chen L
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
    San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.